Expression of fibroblast growth factor-21 in muscle is associated with lipodystrophy, insulin resistance and lipid disturbances in patients with HIV.
<h4>Background</h4>Fibroblast growth factor (FGF)-21 is a novel regulator of glucose and lipid metabolism. Recently, increased FGF-21 mRNA expression in muscle was found in patients with type 2 diabetes, but the role for FGF-21 in muscle is not well understood. Patients with HIV-infectio...
Guardado en:
Autores principales: | Birgitte Lindegaard, Thine Hvid, Thomas Grøndahl, Christian Frosig, Jan Gerstoft, Pernille Hojman, Bente Klarlund Pedersen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/02dde318e27043358bcd651a53000ef9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Lipodystrophy at the insulin injection sites: current trends in epidemiology, diagnostics and prevention
por: Vadim V. Klimontov, et al.
Publicado: (2020) -
Cognitive functions in middle aged individuals are related to metabolic disturbances and aerobic capacity: a cross-sectional study.
por: Maria Pedersen, et al.
Publicado: (2012) -
Prevalence, Risk Factors, and Clinical Characteristics of Lipodystrophy in Insulin-Treated Patients with Diabetes: An Old Problem in a New Era of Modern Insulin
por: Thewjitcharoen Y, et al.
Publicado: (2020) -
Changes in abdominal subcutaneous adipose tissue phenotype following menopause is associated with increased visceral fat mass
por: Julie Abildgaard, et al.
Publicado: (2021) -
Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat
por: Huating Li, et al.
Publicado: (2018)